Adult Surviving Sepis Campaign Guidelines (Hour-1 Bundle) Children's Surviving Sepsis Campaign Guidelines
Adult ICU Liberation Guidelines and Bundle (A-F) Management of Adults with COVID-19
Log In
Forgot username or password? New User? Sign Up Free
SCCM is updating its SCCM Connect Community. Access to SCCM Connect may be limited until April 23.
Help expand critical care research and improve patient outcomes.
Novel Clinical Trial Designs May 26, 2021 1:00 p.m. - 2:00 p.m. Central Time Register
Randomized clinical trials are the gold standard for establishing cause and effect. Traditional approaches have been limited by feasibility and generalizability concerns. In recent years, numerous novel methods have been developed to address these issues. This webcast from Discovery, the Critical Care Research Network, and the Clinical Pharmacy and Pharmacology Section will review key advances, including adaptive randomization, pragmatic designs, platform trials, trials based on electronic health records, and more.
Learn more about Clinical Investigator Proposals and Discovery Clinical Investigators Meetings.
Find a list of the current Endorsed Projects, Discovery Programs, and published works.
Explore services and resources to assist in research including data storage, management and analysis, Central IRB services, and project management.
Connect with like-minded research peers and join the Research Knowledge Education Group (KEG) for access to complete resources. SCCM Members Join the Research KEG Not an SCCM Member? Request to Join the Research KEG
The Viral Infection and Respiratory Illness Universal Study (VIRUS) COVID-19 is registry of current hospital care patterns to allow evaluations of safety and observational effectiveness of COVID-19 practices and to determine the variations in practice across hospitals.
SARI-PREP is a multicenter consortium funded by the National Foundation for the Centers for Disease Control and Prevention. It is being assembled with the goal of providing the infrastructure to rapidly collect prospective data on clinical risks and outcomes, hospital-level stress, and biologic specimens that will aid in the rapid development of diagnostic and treatment approaches.
The STOP-VIRUS Collaborative is a limited-time network of intensive care units focused on improving outcomes for patients with COVID-19. This learning collaborative focuses on interventions aimed at reducing marked variations in the outcomes of critically ill patients unexplained by demographics, comorbidities, and severity of illness.